GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (GREY:SQNMF) » Definitions » Short-Term Debt & Capital Lease Obligation

Sequana Medical NV (Sequana Medical NV) Short-Term Debt & Capital Lease Obligation : $3.43 Mil (As of Jun. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Sequana Medical NV Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Sequana Medical NV's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $3.43 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Sequana Medical NV's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $15.69 Mil.


Sequana Medical NV Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Sequana Medical NV's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV Short-Term Debt & Capital Lease Obligation Chart

Sequana Medical NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only 13.74 0.73 0.32 0.32 5.07

Sequana Medical NV Quarterly Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.32 0.34 5.07 3.43

Sequana Medical NV Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Sequana Medical NV Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Sequana Medical NV (Sequana Medical NV) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
Address
Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (Sequana Medical NV) Headlines

No Headlines